Search results
Results from the WOW.Com Content Network
Chairman and CEO of Paragon Biosciences, LLC Jeff Aronin (born December 8, 1967) is an American investor, entrepreneur, and biotechnology executive. He is founder, chairman and CEO of Paragon Biosciences, LLC, a global life science company that creates, builds, and funds innovative biology-based companies.
William W. Bachovchin is an American chemist/chemical biologist, academic and researcher. He is a professor of Molecular and Chemical Biology at Tufts University School of Medicine, [1] and the founder of three biopharmaceutical companies: Point Therapeutics, Arisaph Pharmaceuticals, and Bach BioSciences.
The company's products are sold under the brand names of Thermo Scientific, Fisher Scientific, and several other recognized brand names (e.g. Applied Biosystems, Invitrogen, Patheon, PPD, and Nalgene). According to company figures, as of 2007, 46% of its sales were in life sciences, 20% in healthcare, and 34% in industrial/environmental and safety.
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury.
Caliper's Discovery Alliances & Services division (CDAS) was created from the acquisitions of NovaScreen, a provider of in vitro & in vivo discovery services. The in vitro service arm of CDAS included in vitro drug discovery and development, including screening assays to define the mode of action, side effect profiles, selectivity, and other relevant activities of drug candidates.
WASHINGTON (Reuters) -U.S. manufacturing contracted at a moderate pace in November, with orders growing for the first time in eight months and factories facing significantly lower prices for inputs.
While Greater Boston area biotechnology companies began announcing layoffs of 30 to 60% of company workforces (with some firms shutting down altogether) as the 2022 stock market decline began, [20] [21] the Greater Boston biotechnology industry workforce continued to grow from approximately 84,000 in 2020 to 114,000 in 2022. [22]
U.S. Sen. Chuck Grassley on Tuesday posted video that showed the aftermath of the killing of Trump shooter Thomas Crooks, with law enforcement agents on a rooftop alongside his body.